Related Experiment Videos
Nanoparticulate computed tomography contrast agents for blood pool and liver-spleen imaging
G S Gazelle1, G L Wolf, G L McIntire
1Center for Imaging and Pharmaceutical Research, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Rationale And Objectives:
We investigated the properties of a group of iodine-containing, insoluble compounds formulated as nanoparticles for use as potential blood pool and liver-spleen contrast agents.
Methods:
High-resolution, quantitative computed tomography (CT) was performed prior to and at intervals following the intravenous administration of the contrast agents to rabbits. Time-density characteristics for three organs were evaluated.
Results:
Excellent enhancement of blood (< or = 232 Hounsfield units [HU]), liver (< or = 263 HU), and spleen (< or = 350 HU) was achieved at the administered dose of 3.0 ml/kg. The composition of the agents influenced the biodistribution, as well as the residence time in blood, and time to peak enhancement in liver.
Conclusion:
Iodinated nanoparticulate compounds are promising CT contrast agents. Development of agents with desirable pharmacokinetic and biodistribution profiles may permit application-specific contrast enhancement.